GORMAN KEVIN CHARLES

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1,013.36
Insider Sells Quantity
59
Insider Sells Sum
$109.08M

Insider Activity of GORMAN KEVIN CHARLES

According to the SEC Form 4 filings, GORMAN KEVIN CHARLES, being in a position of

  1. Chief Executive Officer at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 178711 share for $23.82M,
    over all time since 2004-02-10, has bought 0 shares, and sold 1579558 shares for $109.02M.

The largest purchase of all time was on 2024-02-13 and amounted to 53 shares of Xencor, Inc. for $1,013.

The largest sale of all time was on 2021-01-08 and amounted to 308250 shares of Neurocrine Biosciences, Inc. for $33.97M.

Biography of GORMAN KEVIN CHARLES

No biography is available at this moment.

2024-09-27SaleXencor, Inc.
XNCR
director
2,654
0.0038%
$20.68$54,885+15.11%
2024-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,832
0.0029%
$133.02$376,700+0.58%
2024-02-13PurchaseXencor, Inc.
XNCR
director
53
<0.0001%
$19.12$1,013+12.55%
2024-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0022%
$134.15$305,052+0.11%
2024-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,040
0.0031%
$142.18$432,218-5.87%
2024-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,707
0.0027%
$140.69$380,845-3.68%
2024-01-09SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
62,023
0.0632%
$134.01$8.31M+0.79%
2024-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
105,835
0.1071%
$132.44$14.02M+0.88%
2023-08-21SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
9,328
0.0095%
$107.40$1M+23.1%
2023-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0023%
$104.30$237,185+0.32%
2023-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
23,730
0.0241%
$102.42$2.43M+0.86%
2023-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,040
0.0032%
$105.68$321,259-0.39%
2023-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,707
0.0028%
$110.08$297,997-5.7%
2022-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0024%
$79.49$180,768+28.58%
2022-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
8,710
0.0091%
$80.82$703,907+26.82%
2021-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
10,466
0.011%
$116.75$1.22M-19.67%
2021-02-05SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,422
0.0025%
$114.16$276,504-18.56%
2021-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
308,250
0.3218%
$110.22$33.97M-14.99%
2020-11-12SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,390
0.0036%
$90.78$307,748+6.08%
2020-08-05SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,390
0.0036%
$118.91$403,101-17.85%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.